{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:10:05Z","timestamp":1744150205306,"version":"3.40.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T00:00:00Z","timestamp":1279843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T00:00:00Z","timestamp":1279843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12032-010-9626-9","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T20:58:30Z","timestamp":1279832310000},"page":"1601-1603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia"],"prefix":"10.1007","volume":"28","author":[{"given":"Grzegorz","family":"Helbig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Wo\u017aniczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Wieczorkiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Paj\u0105k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomira","family":"Kyrcz-Krzemien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,23]]},"reference":[{"key":"9626_CR1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-89-5-677","volume":"89","author":"HM Golomb","year":"1978","unstructured":"Golomb HM, Catovsky D, Golde DW. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978;89:677\u201382.","journal-title":"Ann Intern Med"},{"key":"9626_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1056\/NEJM199004193221605","volume":"322","author":"LD Piro","year":"1990","unstructured":"Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New Engl J Med. 1990;322:1117\u201321.","journal-title":"New Engl J Med"},{"key":"9626_CR3","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1200\/JCO.1995.13.9.2431","volume":"19","author":"BD Cheson","year":"1995","unstructured":"Cheson BD. Infectious and immunosuppressive complications of purine nucleoside analog therapy. J Clin Oncol. 1995;19:2431\u201348.","journal-title":"J Clin Oncol"},{"key":"9626_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/sj.leu.2403418","volume":"18","author":"U Jehn","year":"2004","unstructured":"Jehn U, Bartl R, Dietzfelbinger H, Haferlach T, Heinemann V. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine. Leukemia. 2004;18:1476\u201381.","journal-title":"Leukemia"},{"key":"9626_CR5","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V83.10.2906.2906","volume":"83","author":"JF Seymour","year":"1994","unstructured":"Seymour JF, Kurzrock R, Freireich EJ, Estey EH. 2-chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood. 1994;83:2906\u201311.","journal-title":"Blood"},{"key":"9626_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/blood-2009-06-195370","volume":"115","author":"MR Grever","year":"2010","unstructured":"Grever MR. How i treat hairy cell leukemia. Blood. 2010;115:21\u20138.","journal-title":"Blood"},{"key":"9626_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2257.1997.00229.x","volume":"19","author":"RJ Frewin","year":"1997","unstructured":"Frewin RJ, Provan D, Smith AG. Myelodysplasia occurring after fludarabine treatment for chronic lymphocytic leuekmia. Clin Lab Haem. 1997;19:151\u20132.","journal-title":"Clin Lab Haem"},{"key":"9626_CR8","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1365-2141.1998.00612.x","volume":"100","author":"JA Orchard","year":"1998","unstructured":"Orchard JA, Bolam S, Oscier DG. Association of myelodysplastic changes with purine analogues. Brit J Haematol. 1998;100:677\u20139.","journal-title":"Brit J Haematol"},{"key":"9626_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2257.1998.00118.x","volume":"20","author":"E Psiachou-Leonard","year":"1998","unstructured":"Psiachou-Leonard E, Bain BJ. Persistent bone marrow failure with dysplastic features following pentostatin therapy for hairy cell leukaemia. Clin Lab Haem. 1998;20:195\u20137.","journal-title":"Clin Lab Haem"},{"key":"9626_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1046\/j.1365-2141.2001.02622-2.x","volume":"112","author":"T Robak","year":"2001","unstructured":"Robak T, Kasznicki M, Blonski JZ, Dmoszynska A, Skotnicki A. Pure red cell aplasia in patients with chronic lymphocytic leukemia treated with cladribine. Brit J Haematol. 2001;112:1083\u20135.","journal-title":"Brit J Haematol"},{"key":"9626_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","volume":"106","author":"P Chadha","year":"2005","unstructured":"Chadha P, Rademaker AW, Mendiratta P, et al. Treatment of hairy cell leukemia with 2-chlorodeoxysdenosine (2-CdA): long-term follow-up of the Northwestern University experience. Blood. 2005;106:241\u20136.","journal-title":"Blood"},{"key":"9626_CR12","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1182\/blood-2006-08-042929","volume":"109","author":"T Robak","year":"2007","unstructured":"Robak T, et al. Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial. Blood. 2007;109:3672\u20135.","journal-title":"Blood"},{"key":"9626_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","volume":"145","author":"M Else","year":"2009","unstructured":"Else M, et al. Long-term follow-up of 233 patients with hairy cell leukaemia treated initially with pentostatin or cladribine, at a median of 16\u00a0years from diagnosis. Brit J Haematol. 2009;145:733\u201340.","journal-title":"Brit J Haematol"},{"key":"9626_CR14","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1182\/blood.V84.12.4310.bloodjournal84124310","volume":"84","author":"DJ Ellison","year":"1999","unstructured":"Ellison DJ, et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 1999;84:4310\u20135.","journal-title":"Blood"},{"key":"9626_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1034\/j.1600-0609.2001.00308.x","volume":"66","author":"S Gillis","year":"2001","unstructured":"Gillis S, Amir G, Bennett M, Polliack A. Unexpectedly high incidence of hypoplastic\/aplastic foci in bone marrow biopsies of hairy cell leukemia patients in remission following 2-chlorodeoxydenosine. Eur J Haematol. 2001;66:7\u201310.","journal-title":"Eur J Haematol"},{"key":"9626_CR16","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1365-2141.2010.08178.x","volume":"149","author":"C Launes","year":"2010","unstructured":"Launes C, et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Brit J Haematol. 2010;149:874\u20138.","journal-title":"Brit J Haematol"},{"key":"9626_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12185-009-0464-5","volume":"91","author":"MA Kharfan-Dabaja","year":"2010","unstructured":"Kharfan-Dabaja MA, et al. Influenza A\/pandemic 2009\/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol. 2010;91:124\u20137.","journal-title":"Int J Hematol"},{"key":"9626_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1600-0609.2008.01190.x","volume":"82","author":"R Benz","year":"2009","unstructured":"Benz R, Siciliano RD, Stusi G, Fehr J. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia. Eur J Haematol. 2009;82:194\u2013200.","journal-title":"Eur J Haematol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9626-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-010-9626-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9626-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9626-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:53:24Z","timestamp":1744149204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-010-9626-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,23]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9626"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9626-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"type":"print","value":"1357-0560"},{"type":"electronic","value":"1559-131X"}],"subject":[],"published":{"date-parts":[[2010,7,23]]},"assertion":[{"value":"29 June 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}